**PURPOSE:** Current dermal replacement products perform sub-optimally in complex wound beds, such as those that have been irradiated or those with exposed hardware, mostly as a result of insufficient cell invasion and vascularization. Angiogenesis is the result of multi-step processes which involve complex interactions between endothelial cells and their microenvironment. Cells sense the rigidity of their environment in a process called mechanotransduction, which is effected through integrin-mediated adhesions. Directional cell migration based upon substrate rigidity has previously been observed in a process termed durotaxis. We have fabricated a novel micropatterned microsphere scaffold (MSS) composed of differential densities of type I collagen in order to harness these signaling cues and promote rapid cell invasion and vascularization. Herein we compare the performance of MSS to a widely utilized, commercially available dermal replacement product (Integra®) *in vitro* and *in vivo*.

**METHODS:** Microspheres composed of 1% type I collagen 50-150um in diameter were created and encased in a 0.3% type I collagen bulk. For our *in vitro* study, polydimethylsiloxane (PDMS) wells of 4mm diameter and 2mm height were filled with the microsphere scaffolds. 3mm Integra® disks were placed inside PDMS wells. Non-microsphere containing 1% and 0.3% collagen scaffolds served as controls. A monolayer of human umbilical vein endothelial cells (HUVEC) was seeded onto this three-dimensional platform, stimulated with 1uM sphingosine-1-phosphate, and cultured for 3 days. The collagen hydrogels were then imaged using confocal microscopy and z-stacks obtained to quantify cell invasion. For the *in vivo* study, 8x2mm MSS disks were created, along with 1% and 0.3% collagen controls. 8mm Integra® disks were created, and the silicone layer was removed to allow invasion from either side (comparable to the other discs). A disk of each type was then implanted subcutaneously in the dorsum of 8-week old wild-type mice. The scaffolds were removed at 7 and 14 days, imaged, and analyzed with ImageJ.

**RESULTS:** *In vitro* results demonstrated significantly higher cell counts in both MSS and Integra® scaffolds compared to controls (p\<0.001). Invading HUVEC penetrated significantly deeper in MSS compared to Integra® (mean depth of 73.5um vs. 40um, p\<0.001), as well as 0.3% and 1% controls (mean depth of 13.4um and 12.2um respectively, p\<0.001). *In vivo* results demonstrated robust cellular invasion throughout depth of the MSS construct, with more cells reaching the equator of the scaffold compared to Integra® and controls at both 7 days (p\>0.05) and 14 days (p=0.03). Immunohistochemistry verified the presence of CD31 positive, CD45 negative cells within the MSS constructs.

**CONCLUSION:** These studies demonstrate superior cellular invasion of MSS both *in vitro* and *in vivo* compared to the current gold standard dermal regenerative template. Our novel hydrogel scaffold composed only of differential densities of type I collagen harnesses mechanical cues to significantly enhance cellular migration into the graft, offering a promising alternative to currently available dermal replacement products.
